NYSE:COO - Cooper Companies Stock Price, Price Target & More

Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

Cooper Companies announced a semiannual dividend on Friday, January 5th. Investors of record on Tuesday, January 23rd will be given a dividend of $0.03 per share on Friday, February 9th. This represents a yield of 0.03%. The ex-dividend date of this dividend is Monday, January 22nd. View Cooper Companies' Dividend History.

Cooper Companies announced that its Board of Directors has authorized a share repurchase plan on Friday, April 7th 2017, which authorizes the company to repurchase $500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 5.2% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board of directors believes its stock is undervalued.

Cooper Companies Inc (NYSE:COO) posted its quarterly earnings results on Thursday, June, 7th. The medical device company reported $2.86 EPS for the quarter, beating the Zacks' consensus estimate of $2.84 by $0.02. The medical device company earned $631.30 million during the quarter, compared to analysts' expectations of $627.49 million. Cooper Companies had a return on equity of 17.14% and a net margin of 5.58%. Cooper Companies's revenue for the quarter was up 20.8% on a year-over-year basis. During the same period in the prior year, the company earned $2.50 EPS. View Cooper Companies' Earnings History.

Cooper Companies is scheduled to release their next quarterly earnings announcement on Wednesday, August, 29th 2018. View Earnings Estimates for Cooper Companies.

Cooper Companies updated its FY18 earnings guidance on Thursday, June, 7th. The company provided EPS guidance of $11.70-11.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.79. The company issued revenue guidance of $2.52-2.55 billion, compared to the consensus revenue estimate of $2.53 billion.

13 equities research analysts have issued 1 year price targets for Cooper Companies' stock. Their forecasts range from $231.00 to $285.00. On average, they expect Cooper Companies' stock price to reach $265.40 in the next twelve months. View Analyst Ratings for Cooper Companies.

Some companies that are related to Cooper Companies include Express Scripts (ESRX), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), Illumina (ILMN), Zoetis (ZTS), Humana (HUM), BEXIMCO PHARMAC/S GDR REGS (BXP), Vertex Pharmaceuticals (VRTX), Baxter International (BAX), HCA Healthcare (HCA), Regeneron Pharmaceuticals (REGN), Edwards Lifesciences (EW), ASTELLAS PHARMA/ADR (ALPMY), Fresenius Medical Care AG & Co. (FMS) and Takeda Pharmaceutical (TKPYY).

Headlines about COO stock have been trending somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Cooper Companies earned a media sentiment score of 0.16 on Accern's scale. They also assigned headlines about the medical device company an impact score of 45.81 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Cooper Companies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.44%), Massachusetts Financial Services Co. MA (5.57%), GENERATION INVESTMENT MANAGEMENT LLP (5.20%), Amundi Pioneer Asset Management Inc. (2.15%), Westfield Capital Management Co. LP (1.45%) and Frontier Capital Management Co. LLC (1.43%). Company insiders that own Cooper Companies stock include A Thomas Bender, Albert G White III, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Paul L Remmell, Randal Golden, Robert S Weiss, Stanley Md Zinberg and William A Kozy. View Institutional Ownership Trends for Cooper Companies.

COO stock was sold by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., OppenheimerFunds Inc., American Century Companies Inc., Federated Investors Inc. PA, Schroder Investment Management Group, Victory Capital Management Inc., Prudential Financial Inc. and Bamco Inc. NY. Company insiders that have sold Cooper Companies company stock in the last year include A Thomas Bender, Allan E Rubenstein, Carol R Kaufman, Gary S Petersmeyer, Michael Kalkstein, Paul L Remmell, Randal Golden, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies.

COO stock was purchased by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Ceredex Value Advisors LLC, FIL Ltd, Massachusetts Financial Services Co. MA, Westfield Capital Management Co. LP, Wells Fargo & Company MN, Lord Abbett & CO. LLC and New York State Common Retirement Fund. View Insider Buying and Selling for Cooper Companies.

Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of COO stock can currently be purchased for approximately $234.47.

Cooper Companies has a market capitalization of $11.38 billion and generates $2.14 billion in revenue each year. The medical device company earns $372.90 million in net income (profit) each year or $9.70 on an earnings per share basis. Cooper Companies employs 11,800 workers across the globe.

Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]